Marion Gruber, former director of the FDA’s Office of Vaccines Research and Review

FDA emails show how vac­cine leader ques­tioned 'hy­per-ac­cel­er­at­ed' 2021 re­view of Pfiz­er shot

The FDA’s top vac­cine of­fi­cial raised con­cerns that a sharply ac­cel­er­at­ed process to re­view and for­mal­ly ap­prove Pfiz­er’s Covid-19 vac­cine would un­der­mine pub­lic con­fi­dence in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.